KODIAK SCIENCES INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
KODIAK SCIENCES INC. (KOD) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 52.17 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-10
- KODIAK SCIENCES INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 52.17M shares, a 1.16% increase year-over-year.
- KODIAK SCIENCES INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 51.99M shares, a 8.19% increase year-over-year.
- KODIAK SCIENCES INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 51.88M shares, a 14.97% increase year-over-year.
- KODIAK SCIENCES INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 51.57M shares, a 14.69% increase year-over-year.
- KODIAK SCIENCES INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 51.79M shares, a 13.22% increase from fiscal 2020.
- KODIAK SCIENCES INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 45.74M shares, a 20.84% increase from fiscal 2019.
- KODIAK SCIENCES INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 37.85M shares, a 152.75% increase from fiscal 2018.
- KODIAK SCIENCES INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 14.98M shares, a 99.28% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 52.17M shares 10-Q · filed 2022-05-10 | 52.08M shares derived: average of 2 quarters · filed 2022-05-10 | 52.01M shares derived: average of 3 quarters · filed 2022-05-10 | 51.90M shares derived: average of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | 51.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 51.93M shares derived: average of 2 quarters · filed 2022-03-01 | 51.81M shares derived: average of 3 quarters · filed 2022-03-01 | 51.79M shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 51.88M shares 10-Q · filed 2021-11-09 | 51.72M shares derived: average of 2 quarters · filed 2021-11-09 | 51.72M shares 10-Q · filed 2021-11-09 | 50.77M shares derived: average of 4 quarters · filed 2022-05-10 |
| 2021-06-30 | 51.57M shares 10-Q · filed 2021-08-09 | 51.64M shares 10-Q · filed 2021-08-09 | 50.40M shares derived: average of 3 quarters · filed 2022-05-10 | 49.08M shares derived: average of 4 quarters · filed 2022-05-10 |
| 2021-03-31 | 51.57M shares 10-Q · filed 2022-05-10 | 49.81M shares derived: average of 2 quarters · filed 2022-05-10 | 48.25M shares derived: average of 3 quarters · filed 2022-05-10 | 47.43M shares derived: average of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | 48.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 46.59M shares derived: average of 2 quarters · filed 2022-03-01 | 46.05M shares derived: average of 3 quarters · filed 2022-03-01 | 45.74M shares 10-K · filed 2022-03-01 |
| 2020-09-30 | 45.12M shares 10-Q · filed 2021-11-09 | 45.04M shares derived: average of 2 quarters · filed 2021-11-09 | 44.97M shares 10-Q · filed 2021-11-09 | 43.61M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | 44.97M shares 10-Q · filed 2021-08-09 | 44.90M shares 10-Q · filed 2021-08-09 | 43.11M shares derived: average of 3 quarters · filed 2022-03-01 | 41.67M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | 44.82M shares 10-Q · filed 2021-05-10 | 42.18M shares derived: average of 2 quarters · filed 2022-03-01 | 40.57M shares derived: average of 3 quarters · filed 2022-03-01 | 39.75M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | 39.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 38.44M shares derived: average of 2 quarters · filed 2022-03-01 | 38.06M shares derived: average of 3 quarters · filed 2022-03-01 | 37.85M shares 10-K · filed 2022-03-01 |
| 2019-09-30 | 37.33M shares 10-Q · filed 2020-11-09 | 37.31M shares derived: average of 2 quarters · filed 2020-11-09 | 37.29M shares 10-Q · filed 2020-11-09 | 37.12M shares derived: average of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | 37.29M shares 10-Q · filed 2020-08-10 | 37.27M shares 10-Q · filed 2020-08-10 | 37.05M shares derived: average of 3 quarters · filed 2021-03-01 | 29.75M shares derived: average of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | 37.25M shares 10-Q · filed 2020-05-11 | 36.93M shares derived: average of 2 quarters · filed 2021-03-01 | 27.24M shares derived: average of 3 quarters · filed 2021-03-01 | 22.37M shares derived: average of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | 36.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 22.23M shares derived: average of 2 quarters · filed 2021-03-01 | 17.41M shares derived: average of 3 quarters · filed 2021-03-01 | 14.98M shares 10-K · filed 2021-03-01 |
| 2018-09-30 | 7.85M shares 10-Q · filed 2019-11-12 | 7.80M shares derived: average of 2 quarters · filed 2019-11-12 | 7.76M shares 10-Q · filed 2019-11-12 | 7.73M shares derived: average of 4 quarters · filed 2020-03-16 |
| 2018-06-30 | 7.76M shares 10-Q · filed 2019-08-14 | 7.72M shares 10-Q · filed 2019-08-14 | 7.69M shares derived: average of 3 quarters · filed 2020-03-16 | 7.65M shares derived: average of 4 quarters · filed 2020-03-16 |
| 2018-03-31 | 7.68M shares 10-Q · filed 2019-05-15 | 7.65M shares derived: average of 2 quarters · filed 2020-03-16 | 7.62M shares derived: average of 3 quarters · filed 2020-03-16 | |
| 2017-12-31 | 7.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 7.59M shares derived: average of 2 quarters · filed 2020-03-16 | 7.52M shares 10-K · filed 2020-03-16 | |
| 2017-09-30 | 7.55M shares 10-Q · filed 2018-11-16 | 7.48M shares 10-Q · filed 2018-11-16 | ||
| 2016-12-31 | 7.21M shares 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |